相关实验视频

Updated: Jan 14, 2026

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

15.3K

在CD30阳性淋巴瘤患者中,随机选择的Brentuximab-Vedotin与高剂量化疗的II期研究

Christian Rausch1, Ulrike Bacher2, Manuela Rabaglio3

  • 1Department of Medicine III, LMU University Hospital, Munich, Germany.

Hematological oncology
|October 21, 2025
PubMed
概括

在BeEAM高剂量化疗中添加布伦图西马布-维多丁 (BV) 并没有改善复发性霍奇金淋巴瘤或外围T细胞淋巴瘤患者的结局. 该组合还显示肺毒性增加,没有显著的生存益处.

关键词:
自体干细胞移植自体干细胞移植布伦图西马布-维多丁是一种霍奇金淋巴瘤是一种淋巴瘤.周围T细胞淋巴瘤第二阶段研究研究.

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.9K
Modeling Chemotherapy Resistant Leukemia In Vitro08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.5K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K